Dewpoint Therapeutics

What makes our approach to drug discovery unique? Our revolutionary #condensate science, our world-class expert team and our state-of-the-art AI/ML-powered integrated platform, all focused on addressing diseases of high unmet need. Tour our Boston MA site: youtu.be/yQ2Nk8-0V6I

At Dewpoint, we built a flexible integrated platform to enable a broad range of assay types & custom workflows, from target discovery & validation to drug discovery & development. See how we deploy our platform to support programs across many disease areas youtu.be/JxG8UD7jEq8

Announcing the nomination of DPTX3496, the second #cmod development candidate that targets the oncogenic driver function of beta catenin in Wnt-driven cancers. IND-enabling studies are progressing and IND filing is planned for the second half of the year. tinyurl.com/26xde734

We discover #cmods using industrial-scale screening of condensate phenotypes. Our digitally integrated experimental infrastructure, powered by our AI/ML-ERSAi platform, manages, processes & analyzes data produced during screening & optimization. Learn more youtu.be/5uF1V7a7O3E

Meet the Dewpoint team at #SLAS2025! Learn about our digitally integrated, high-throughput screening and optimization platform, and how we apply it to advance revolutionary programs in the #neurodegeneration and #oncology therapeutic areas. @YSPTSPS